Mitschrift und Gedchtnisprotokoll der Beratung durch Dr. Manuela Neumann
Datum: 8.1.2018
Chronische Sinusitis ...
C. Bachert, G. Holtappels, Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options, Current Topics in Otorhinolaryngology - Head and Neck Surgery 2015, Vol. 14, pp 1-40 (published: 2015-12-22) - im Cache, excerpts
Research in immunology has brought great progress in knowledge of inflammatory processes in the last 2 decades, which also has an impact on the upper airways. Our understanding of the pathophysiology of chronic rhinosinusitis developed from a rather mechanistic point of view with a focus on narrow clefts and mucociliary clearance to the appreciation of a complex network of immunological pathways forming the basis of disease. We today differentiate various forms of inflammation, we start to understand complex immune-regulatory networks and the reasons for their failure, and have already developed innovative approaches for therapy for the most severely ill subjects. Due to this new knowledge in inflammation and remodeling processes within mucosal tissue, specifically on the key driving factors, new diagnostic tools and therapeutic approaches for chronic rhinosinusitis have developed; the differentiation of endotypes based on pathophysiological principles will be crucial for the use of innovative therapies, mostly humanized monoclonal antibodies. Several hundred of those antibodies are currently developed for various indications and will impact our specialty as well as pneumology to a great extent.
Mit Operation (OP bis hinein in die Siebbeinzellen, den hufigsten Ursprungsort der Polypen)
Bachert & Holtappels (2015): Surgeries of recurrences in CRSwNP are frequently performed.
Die Immunreaktion, welche die Probleme (z.B. Polypen) verursacht, ist ztl. variabel, d.h. abhngig von Jahreszeit und Alter.
Gefahrenpunkte & Komplikationen bei der OP
Im vorliegenden Fall (DVT)
Es ist mglich, dass die Sinusitis mit der schmerzhaften Paradontose in Verbindung steht. Der Mechanismus dafr ist unklar.
Post-Operation
Multiresistente Erreger
Version: 14.1.2018
Adresse dieser Seite